ART621

DRUG2 trials

Sponsors

Arana Therapeutics Ltd

Conditions

Rheumatoid Arthritis

Phase 2

Dose Optimisation Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate

CompletedNCT00854685

Arana Therapeutics LtdRheumatoid Arthritis

Start: 2009-02-28End: 2010-01-31Updated: 2010-01-06

Dose Ranging Study of ART621 in Subjects Diagnosed With Rheumatoid Arthritis Taking Methotrexate

TerminatedNCT00928317

Arana Therapeutics LtdRheumatoid Arthritis

Start: 2009-04-30End: 2009-12-31Updated: 2010-01-06